EUVIMEDEUVIMED entdecken
Open Access

In silico cardiac safety assessment using a multi-biomarker approach based on an electrophysiological model of hiPSC-derived cardiomyocytes

Ari Kurniawan Saputra, Ali Ikhsanul Qauli, Aroli Marcellinus, Ki Moo Lim iD

Toxicological Research · 2026-07 · 42 (4) · 517-534

DOI: 10.1007/s43188-026-00341-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Research, online erschienen am 19.03.2026. Verfasst von Ari Kurniawan Saputra und 3 weiteren Autor:innen. Beteiligte Einrichtung: IT Convergence Engineering, Kumoh National Institute of Technology, Gumi, 39177 Republic of Korea. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Torsade de Pointes (TdP) is a potentially fatal ventricular arrhythmia associated with drug-induced disturbances of cardiac repolarization. Because QT interval prolongation alone provides limited mechanistic specificity, the Comprehensive in vitro Proarrhythmia Assay (CiPA) paradigm promotes integrated evaluation using ion-channel pharmacology, in silico electrophysiology, and human stem-cell-based evidence. In this study, we benchmarked the Paci2020 human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) in silico model for CiPA-aligned TdP risk prediction using an interpretable ordinal logistic regression (OLR) framework. Ten mechanistically grounded biomarkers spanning ionic charge balance, action-potential morphology, and calcium handling dynamics were extracted from simulations of 28 CiPA reference drugs across clinically relevant exposures (up to fourfold free peak plasma concentration, Cmax) and evaluated using CiPA-recommended diagnostic metrics under repeated resampling. Single-biomarker models-including qNet and APD90 (a net ionic charge metric and action potential duration at 90% repolarization)-exhibited strong discrimination in some comparisons but did not consistently meet CiPA confidence requirements for reliably excluding high-risk compounds, which motivated the integration of multiple biomarkers. Exhaustive screening of all non-empty biomarker subsets (1023 combinations) identified a parsimonious four-biomarker signature (qNet, Ca_resting, dVm/dtmax, Cycle_length) that satisfied all CiPA acceptance criteria on the independent test set, outperforming the Tomek-ORd benchmark and approaching the performance of the CiPAORdv1.0 adult-ventricular model. Collectively, these findings demonstrate that, despite the immature electrophysiology of hiPSC-CMs, CiPA-grade TdP risk prediction can be achieved through systematic, mechanistically interpretable multi-biomarker integration, supporting the role of hiPSC-CM in silico models as complementary tools for early-stage cardiotoxicity screening. Supplementary Information: The online version contains supplementary material available at 10.1007/s43188-026-00341-3.

Schlagwörter

Stichwörter der Autor:innen

CiPA frameworkIn silico human stem cell-derived cardiomyocytesOrdinal logistic regressionPro-arrhythmic risk predictionTorsade de Pointes

Autor:innen und Institutionen

  • IT Convergence Engineering, Kumoh National Institute of Technology, Gumi, 39177 Republic of Korea.
  • Department of Mechanical Engineering, Institut Teknologi Sepuluh Nopember, Surabaya, Indonesia.
  • Faculty of Advanced Technology and Multidiscipline, Department of Engineering, Universitas Airlangga, Surabaya, Indonesia.
  • Department of Biomedical Engineering, Kumoh National Institute of Technology, Gumi, 39253 Republic of Korea.
  • Meta Heart Inc., Gumi, 39253 Republic of Korea.

ORCID-Profile: Ki Moo Lim

Zitieren

APA

Saputra, A. K., Qauli, A. I., Marcellinus, A., & Lim, K. M. (2026). In silico cardiac safety assessment using a multi-biomarker approach based on an electrophysiological model of hiPSC-derived cardiomyocytes. Toxicological Research, 42(4), 517-534. https://doi.org/10.1007/s43188-026-00341-3

Vancouver

Saputra AK, Qauli AI, Marcellinus A, Lim KM. In silico cardiac safety assessment using a multi-biomarker approach based on an electrophysiological model of hiPSC-derived cardiomyocytes. Toxicological Research. 2026;42(4):517-534. doi:10.1007/s43188-026-00341-3

BibTeX
@article{Saputra2026,
  author = {Saputra, Ari Kurniawan and Qauli, Ali Ikhsanul and Marcellinus, Aroli and Lim, Ki Moo},
  title = {In silico cardiac safety assessment using a multi-biomarker approach based on an electrophysiological model of hiPSC-derived cardiomyocytes},
  journal = {Toxicological Research},
  year = {2026},
  volume = {42},
  number = {4},
  pages = {517--534},
  doi = {10.1007/s43188-026-00341-3}
}
Kostenlos starten →